High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line Cover

.blurhash-client-img { display: none !important; }

High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line

Endocrine Regulations

Volume 52 (2018): Issue 1 (January 2018)

By: Eiji Yamato

Open Access

|Feb 2018

Metrics

DOI: https://doi.org/10.2478/enr-2018-0004 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 21 - 26

Published on: Feb 16, 2018

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

trichostatin A,

histone deacytylase inhibitor,

beta cell line,

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2018 Eiji Yamato, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 52 (2018): Issue 1 (January 2018)Next article